ß2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. (2021)
Attributed to:
ADIPOSE TISSUE DYSFUNCTION AND LIPOTOXICITY
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abk2267
PubMed Identifier: 34910547
Publication URI: http://europepmc.org/abstract/MED/34910547
Type: Journal Article/Review
Volume: 13
Parent Publication: Science translational medicine
Issue: 624
ISSN: 1946-6234